Propofol’s Effects on the Fetal Brain for Non-Obstetric Surgery
AbstractWhile the use of Propofol has been increasing in usage for general surgical procedures since its release to market, there has been little work done on its potential link to neurotoxicity in humans. Only recently, following the release of a warning label from the United States Food and Drug Administration (USFDA) regarding a potential link to “neurotoxicity” in the neonate, did the surgical and anesthesiology communities become more aware of its potential for harm. Given the widespread use of this drug in clinical practice, the warning label naturally raised controversy regarding intrapartum Propofol usage. While intended to generate further studies, the lack of a viable anesthetic alternative raises issues regarding its current usage for surgical procedures in pregnant women. To answer the question whether current evidence is supportive of Propofol usage at its current levels in pregnant women, this review summarizes available evidence of fetal Propofol exposure in animal studies. View Full-Text
Share & Cite This Article
Malhotra, A.; Yosh, E.; Xiong, M. Propofol’s Effects on the Fetal Brain for Non-Obstetric Surgery. Brain Sci. 2017, 7, 107.
Malhotra A, Yosh E, Xiong M. Propofol’s Effects on the Fetal Brain for Non-Obstetric Surgery. Brain Sciences. 2017; 7(8):107.Chicago/Turabian Style
Malhotra, Ajay; Yosh, Emily; Xiong, Ming. 2017. "Propofol’s Effects on the Fetal Brain for Non-Obstetric Surgery." Brain Sci. 7, no. 8: 107.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.